Aegon Stock Gains Momentum After UBS Upgrade
Shares of Aegon (AS: AEGN) have seen an uptick recently, as UBS analysts upgraded their rating from 'neutral' to 'buy'. This positive shift in outlook is primarily attributed to the optimistic projections regarding the company's capital return potential, especially with anticipated share buybacks on the horizon.
Future Share Buybacks: A Key Consideration
UBS analysts are closely watching Aegon’s commitment to executing share buybacks over the long haul. Their forecast suggests that Aegon may initiate recurring share buybacks totaling approximately €300 million starting from 2025, which would result in an attractive all-in yield of around 9%. This yield aligns well with Dutch peers while surpassing the broader sector average.
Special Buyback Programs
The brokerage has also proposed the possibility of a special buyback program valued at around €100 million, which they believe could be unveiled following Aegon's third-quarter earnings report. This announcement is expected on November 15, adding to the ongoing €200 million buyback that is slated for completion by mid-December.
Flexibility with Capital and Investment Strategies
UBS has emphasized Aegon's flexibility concerning its excess capital, particularly its significant stake in ASR, a Dutch insurer in which Aegon maintains a 30% ownership. Should there be no attractive deal opportunities, it is likely that Aegon will opt to return this capital to its shareholders.
Evaluating the ASR Stake
However, UBS expresses caution regarding the potential sale of the ASR stake to finance further buybacks. They suggest that pursuing such a sale may not yield increased value under the present valuations for ASR.
Strategic Moves to Unlock Shareholder Value
Additionally, the analysts pointed to the prospect of de-risking Aegon’s non-core U.S. assets, an initiative that is viewed as a significant opportunity to unlock further value for shareholders. Although U.S. interest rates are currently on the lower side, which may affect the valuation of these assets, minimizing risk could serve as a positive growth catalyst.
Revised Price Target and Long-Term Outlook
In their report, UBS lowered Aegon’s price target slightly from €6.65 to €6.55, a decision influenced by a downward adjustment in the valuation of both the ASR stake and U.S. non-core assets. Yet, despite this slight revision, the analysts maintain a bullish outlook on Aegon’s long-term prospects and capital return strategies, reinforcing their recommendation to buy the stock.
Frequently Asked Questions
What led to UBS upgrading Aegon's stock to 'buy'?
UBS upgraded Aegon's stock due to optimism regarding its capital return potential, especially concerning upcoming share buybacks.
When is Aegon expected to roll out its share buyback programs?
Aegon is expected to start its recurring share buybacks around 2025, with current buyback programs concluding by mid-December.
What is the anticipated yield from Aegon's share buybacks?
The all-in yield from Aegon's expected share buybacks is projected to be around 9%, aligning with Dutch peers and surpassing the sector average.
How does Aegon's stake in ASR affect its capital strategy?
Aegon's 30% stake in ASR provides flexibility in its capital strategy, allowing for potential returns to shareholders instead of pursuing further sales.
What is UBS's revised price target for Aegon?
UBS has revised its price target for Aegon to €6.55 from €6.65, reflecting lower valuations of the ASR stake and non-core assets.
